A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

596

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

levocetirizine dihydrochloride

5mg daily (oral tablet) for 14 days

DRUG

placebo

0mg (matching oral tablet)for 14 days

Trial Locations (26)

Unknown

Scottsdale

Hot Springs

Little Rock

Huntington Beach

Long Beach

Los Angeles

Mission Viejo

Albany

Lilburn

Savannah

Owensboro

Metairie

Winston-Salem

Tulsa

Charleston

Knoxville

Austin

Dallas

El Paso

Fort Worth

Katy

New Braunfels

Plano

San Angelo

San Antonio

Waco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY